Renin-angiotensin system - Considerations for hypertension and kidney
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yim, H.E. | - |
dc.contributor.author | Yoo, K.H. | - |
dc.date.accessioned | 2021-09-09T15:58:27Z | - |
dc.date.available | 2021-09-09T15:58:27Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1738-5997 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/125361 | - |
dc.description.abstract | The kidneys play a fundamental role in the long-term control of arterial pressure by regulating sodium balance and extracellular fluid volume. The renin-angiotensin system (RAS) is at the center of the regulation of hypertension and progressive renal injury. It has gradually become clear that not only systemic RAS, but also intrarenal RAS has specific effects in the pathogenesis and progression of hypertension and renal damage. All of the RAS components are exhibited in the kidney and intrarenal angiotensin II (Ang II) is formed by multiple mechanisms. The demonstration of much enhanced levels of Ang II within specific renal compartments points out selective local regulation of Ang II in the kidney, showing that intrarenal Ang II levels are regulated in a way different from circulating Ang II. The importance of the RAS in involving proper nephrogenesis is also well known, and suppression of the RAS during fetal development may play a key role in mediating the structural and physiological changes observed in models of fetal programming of hypertension. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Electrolyte and Blood Pressure Research | - |
dc.subject | angiotensin 2 receptor | - |
dc.subject | angiotensin converting enzyme 2 | - |
dc.subject | angiotensin II | - |
dc.subject | angiotensin II antagonist | - |
dc.subject | angiotensin receptor antagonist | - |
dc.subject | angiotensinogen | - |
dc.subject | captopril | - |
dc.subject | chymase | - |
dc.subject | dipeptidyl carboxypeptidase inhibitor | - |
dc.subject | prorenin | - |
dc.subject | renin | - |
dc.subject | cardiovascular function | - |
dc.subject | disease association | - |
dc.subject | electrolyte balance | - |
dc.subject | fetus development | - |
dc.subject | glomerulosclerosis | - |
dc.subject | hormonal regulation | - |
dc.subject | human | - |
dc.subject | hypertension | - |
dc.subject | interstitial nephritis | - |
dc.subject | kidney blood flow | - |
dc.subject | kidney development | - |
dc.subject | kidney disease | - |
dc.subject | kidney injury | - |
dc.subject | low birth weight | - |
dc.subject | nonhuman | - |
dc.subject | pathophysiology | - |
dc.subject | prenatal exposure | - |
dc.subject | protein localization | - |
dc.subject | protein protein interaction | - |
dc.subject | receptor blocking | - |
dc.subject | renin angiotensin aldosterone system | - |
dc.subject | review | - |
dc.subject | sodium metabolism | - |
dc.subject | water metabolism | - |
dc.title | Renin-angiotensin system - Considerations for hypertension and kidney | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, K.H. | - |
dc.identifier.doi | 10.5049/EBP.2008.6.1.42 | - |
dc.identifier.scopusid | 2-s2.0-50849083170 | - |
dc.identifier.bibliographicCitation | Electrolyte and Blood Pressure, v.6, no.1, pp.42 - 50 | - |
dc.relation.isPartOf | Electrolyte and Blood Pressure | - |
dc.citation.title | Electrolyte and Blood Pressure | - |
dc.citation.volume | 6 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 42 | - |
dc.citation.endPage | 50 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001255667 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordPlus | angiotensin 2 receptor | - |
dc.subject.keywordPlus | angiotensin converting enzyme 2 | - |
dc.subject.keywordPlus | angiotensin II | - |
dc.subject.keywordPlus | angiotensin II antagonist | - |
dc.subject.keywordPlus | angiotensin receptor antagonist | - |
dc.subject.keywordPlus | angiotensinogen | - |
dc.subject.keywordPlus | captopril | - |
dc.subject.keywordPlus | chymase | - |
dc.subject.keywordPlus | dipeptidyl carboxypeptidase inhibitor | - |
dc.subject.keywordPlus | prorenin | - |
dc.subject.keywordPlus | renin | - |
dc.subject.keywordPlus | cardiovascular function | - |
dc.subject.keywordPlus | disease association | - |
dc.subject.keywordPlus | electrolyte balance | - |
dc.subject.keywordPlus | fetus development | - |
dc.subject.keywordPlus | glomerulosclerosis | - |
dc.subject.keywordPlus | hormonal regulation | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypertension | - |
dc.subject.keywordPlus | interstitial nephritis | - |
dc.subject.keywordPlus | kidney blood flow | - |
dc.subject.keywordPlus | kidney development | - |
dc.subject.keywordPlus | kidney disease | - |
dc.subject.keywordPlus | kidney injury | - |
dc.subject.keywordPlus | low birth weight | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | pathophysiology | - |
dc.subject.keywordPlus | prenatal exposure | - |
dc.subject.keywordPlus | protein localization | - |
dc.subject.keywordPlus | protein protein interaction | - |
dc.subject.keywordPlus | receptor blocking | - |
dc.subject.keywordPlus | renin angiotensin aldosterone system | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | sodium metabolism | - |
dc.subject.keywordPlus | water metabolism | - |
dc.subject.keywordAuthor | Blood pressure | - |
dc.subject.keywordAuthor | Environment | - |
dc.subject.keywordAuthor | Kidney | - |
dc.subject.keywordAuthor | Renin-angiotensin system | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.